I listened to Geron Annual Shareholders Meeting. The company must have good results from the 6 Phase two trials. Four of the trials deal with imetelstat that target the telomerase to arrest cancer cell proliferation. Those Phase two results will be given Dec 2012. The last two, GRN1005 is designed to cross the blood brain barrier,
those two will have results 2Q 2013. Without some kind of good results Geron is done.
Good luck in this rigged casino,
No comments:
Post a Comment